Relationship between systemic and cerebral vascular disease and brain structure integrity in normal elderly individuals

Journal of Alzheimer's Disease

Volumn 44, Issue 1, 2015, Pages 319-328

  Riverol, Mario ^a,b   Becker, James T ^b   López, Oscar L ^b   Raji, Cyrus A ^b   Thompson, Paul M ^c   Carmichael, Owen T ^d   Gach, H Michael ^b,e   Longstreth, William T ^f   Fried, Linda ^b,g   Tracy, Russell P ^h   Kuller, Lewis H ⁱ  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e University of Pittsburgh   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^h UNIVERSITY OF VERMONT   (United States)

ⁱ UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cognitive impairment; Cystatin C; Gray matter volume; White matter lesions

Indexed keywords

CYSTATIN C;

AGED; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN SIZE; CEREBROVASCULAR DISEASE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULAR DYSFUNCTION; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTEMIC DISEASE; SYSTEMIC SMALL VESSEL DISEASE; WHITE MATTER LESION; ANALYSIS OF VARIANCE; BRAIN; IMAGE PROCESSING; PATHOLOGY; PERIPHERAL VASCULAR DISEASE; PREDICTIVE VALUE; RETROSPECTIVE STUDY; STATISTICAL MODEL; VERY ELDERLY; WHITE MATTER;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; WHITE MATTER;

EID: 84920865702     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141077     Document Type: Article

References (58)

1. Longstreth WT, Arnold AM, Manolio T, Burke G, Bryan N, Jungreis CA, O'Laery D (2000) Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3301 elderly people. The cardiovascular health study. Neuroepidemiology 19, 30-42.
2. Longstreth WT, Arnold AM, Beauchamp NJ, Manolino TA, Lefkowitz D, Jungreis C, Hirsch CH, O'Leary DH, Furberg CD (2005) Incidence, manifestations, and predictors of working white matter on serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke 36, 56-61.
3. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler M (2003) Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam scan study. Stroke 34, 1126-1129.
4. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2008) Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39, 2712-2719.
5. Manolio TA, Burke GL, O'Leary DH, Evans G, Beauchamp N, Knepper L, Ward B (1999) Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: The Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol 19, 356-365.
6. Mogi M, Horiuchi M (2011) Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Prac 2011, 306189.
7. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM, Carmelli D (1998) Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 51, 986-993.
8. de Leeuw F-E, dr Groot JC, Oudkerk M, Witterman JCM, Hofman A, van Gjin J, Breteler MMB (2002) Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125, 765-772.
9. Dufouil C, de Kersaint-Gilly A, Besancon V, Levy C, Auffray E, Brunnereau L, Alperovitch A, Tzourio C(2001) Longitudinal study of blood pressure and white matter hyperintensities. The EVA MRI Cohort. Neurology 56, 921-926.
10. Gianaros PJ, Greer PJ, Ryan CM, Jennings JR (2006) Higher blood pressure predicts lower regional grey matter volume: Consequences on short-term information processing. Neuroimage 31, 754-765.
11. de Leeuw F-E, de Groot JC, Oudkerk M, Witeman JCM, Hofman A, van Gijn J, Breteler MMB (2000) Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke 31, 425-429.
12. Wen W, Sachdev PS, Chen X, Anstey K (2006) Gray matter reduction is correlated with white matter hyperintensity volume: A voxel-based morphometric study in a large epidemiological sample. Neuroimage 29, 1031-1039.
13. Raji CA, Lopez OL, Kuller LH, Carmichael OT, Longstreth WT Jr, Gach HM, Boardman J, Bernick CB, Thompson PM, Becker JT (2012) White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 33, 834 e837-816.
14. Rosano C, Brach J, Studenski S, Longstreth WT Jr, Newman AB (2007) Gait variability is associated with subclinical brain vascular abnormalities in high-functioning older adults. Neuroepidemiology 29, 193-200.
15. Kramer JH, Mungas D, Reed BR, Wetzel ME, Burnett MM, Miller BL, Weiner MW, Chui HC (2007) Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 21, 412-418.
16. de Groot JC, de Leeuw F-E, Oudkerk M, van Gijn J, Hofman A, Jolles J, Brereler MMB (2002) Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 52, 335-341.
17. Kuller LH, Shemanski L, Manolio T, Haan M, Fried L, Bryan N, Burke GL, Tracy R, Bhadelia R (1998) Relationship between ApoE, MRI findings, and cognitive function in the cardiovascular health study. Stroke 29, 388-398.
18. Mitchell GF (2008) Effects of central arterial aging on the structure and function of the peripheral vasculature: Implications for end-organ damage. J Appl Physiol 105, 1652-1660.
19. Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, Garcia M, Aspelund T, Harris TB, Gudnason V, Launer LJ (2011) Arterial stiffness, pressure and flow pulsatility and brain structure and function: The Age, Gene/Environment Susceptibility-Reykjavik study. Brain 134, 3398-3407.
20. O'Rourke MF, Safar ME (2005) Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy. Hypertension 46, 200-204.
21. Wada M, Nagasawa H, Kawanami T, Kurita K, Daimon M, Kubota I, Kayama T, Kato T (2010) Cystatin C as an index of cerebral small vessel disease: Results of a cross-sectional study in community-based Japanese elderly. Eur J Neurol 17, 383-390.
22. van den Noortgate NJ, Janssens WH, Delanghe JR, Afschrift MB, Lameire NH (2002) Serum cystatin concentration compared with other markers of glomercural filtration rate in the old. Am J Geriatr Psychiatry 50, 1278-1282.
23. Madero M, Sarnak MJ (2009) Association of cystatin C with adverse outcomes. Curr Opin Nephrol Hypertens 18, 258-263.
24. Shlipak MG, Fyr CLW, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, Satterfield S, Cummings SR, Newman AB, Fried LF (2006) Cystatin C and mortality risk in the elderly: The health, aging, and body composition study. J Am Soc Nephrol 17, 254-261.
25. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman A, Siscovick DS, Stehman-Breen C (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Eng J Med 352, 2049-2060.
26. Sarnak MJ, Katz R, Fried LF, Siscovick DS, Kestenbaum B, Seliger SL, Rifkin D, Tracy R, Newman A, Shlipak MG (2008) Cystatin C and aging success. Arch Intern Med 168, 147-153.
27. Seliger SL, Longstreth WT, Katz R, Manolio T, Fried LF, Shlipak M, Stehman-Breen CO, Newman A, Sarnak M, Gillen DL, Bleyer A, Siscovick DS (2005) Cystatin C and subclinical brain infarction. J Am Soc Nephrol 16, 3721-3727.
28. Yaffe K, Lindquist K, Shlipak MG, Simonsick E, Fried L, Rosano C, Satterfield S, Atkinson H, Windham BG, Kurella-Tamura M(2008) Cystatin C as a marker of cognitive function in elders: Findings from the health ABC study. Ann Neurol 63, 798-802.
29. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 2672-2713.
30. Kuller LH, Lopez OL, Newman A, Beauchamp NJ, Burke G, Dulberg C, Fitzpatrick A, Fried L, Haan MN (2003) Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 22, 13-22.
31. Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N (2003) Evaluations of dementia in the cardiovascular health cognition study. Neuroepidemiology 22, 1-12.
32. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty B, Rautaharju P, Tracy RP,Weiler PG (1991) The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1, 263-276.
33. Fitzpatrick AL, Kuller LH, Ives D, Lopez OL, JagustW, Breitner J, Jones B, Lyketsos C, Dulberg C (2004) Incidence and prevalence of dementia in the cardiovascular health study. J Am Geriatr Soc 52, 195-204.
34. Bryan RN, Manolio TA, Scertz LD, Jungreis C, Poirier VC, Elster AD, Kronmal RA (1994) A method for using MR to evaluate the effects of cardiovascular disease on the brain: The cardiovascular health study.AmJ Neuroradiol 15, 1625-1633.
35. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson MC, Kuller LH (2003) Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognitive Study Part 1. Arch Neurol 60, 1385-1389.
36. (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20, 1183-1197.
37. Teng EL, Chui HC (1987) Wechsler Adult Intelligence Scale-Revised. J Clin Psychiatry 48, 314-318.
38. Wechsler D (1981) Wechsler Adult Intelligence Scale-Revised, The Psychological Corporation, New York.
39. Benton AL (1972) Abbreviated versions of the Visual Retention Test. J Psychol 80, 189-192.
40. Benton AL, Hamsher K, Varney NR, Spreen O(1983) Contributions to neuropsychological assessment. A clinical manual. Oxford University Press, New York.
41. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Garden JM, Fried LP, Steinberg EP, Bryan RN (1994) Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 25, 318-327.
42. Spears JR, Greer PJ, Ziolko SK, Aizenstein HJ, Carmichael O, Becker JT, Meltzer CC (2005) Evaluation of an age-specific neurological template. Annual Meeting of the Organization of Human Brain Mapping. Toronto, Ontario, Canada.
43. Holmes CJ, Hoge R, Collins L, Woods R, Toga AW, Evans AC (1998) Enhancement of MR images using registration for signal averaging. J Comput Assist Tomogr 22, 324-333.
44. Knopman DS, Mosley TH Jr, Bailey KR, Jack CR Jr, Schwartz GL, Turner ST (2008) Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships. J Neurol Sci 271, 53-60.
45. Yakushiji Y, Nanri Y, Hirotsu T, Nishihara M, Hara M, Nakajima J, Eriguchi M, Nishiyama M, Hara H, Node K (2010) Marked cerebral atrophy is correlated with kidney dysfunction in nondisabled adults. Hypertens Res 33, 1232-1237.
46. Baron RM, Kenny DA (1986) The Moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51, 1173-1182.
47. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB (2005) Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging 26(Suppl 1), 11-16.
48. Wolf PA, Beiser A, Elias MF, Au R, Vasan RS, Seshadri S (2007) Relation of obesity to cognitive function: Importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res 4, 111-116.
49. Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog I (2004) A 24-year follow-up of body mass index and cerebral atrophy. Neurology 63, 1876-1881.
50. Pannacciulli N, Del Parigi A, Chen K, Le DS, Reiman EM, Tataranni PA (2006) Brain abnormalities in human obesity: A voxel-based morphometric study. Neuroimage 31, 1419-1425.
51. Taki Y, Kinomura S, Sato K, Inoue K, Goto R, Okada K, Uchida S, Kawashima R, Fukuda H (2008) Relationship between body mass index and gray matter volume in 1,428 healthy individuals. Obesity (Silver Spring) 16, 119-124.
52. Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR Jr, Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM (2010) A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A 107, 8404-8409.
53. Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, Hua X, Leow AD, Toga AW, Thompson PM(2010) Brain structure and obesity. Hum Brain Mapp 31, 353-364.
54. den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, Breteler MM (2003) Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46, 1604-1610.
55. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM(2005) C-reactive protein and cerebral small-vessel disease: The Rotterdam Scan Study. Circulation 112, 900-905.
56. Lieb W, Beiser A, Vasan RS, Tan ZS, Au R, Harris TR, Roubenoff R, Auerbach S, DeCarli C, Wolf PA, Seshadri S (2009) Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 302, 2562-2572.
57. Colcombe SJ, Erickson KI, Scalf PE, Kim JS, Prakash R, McAuley E, Elavsky S, Marquez DX, Hu L, Kramer AF (2006) Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci 61, 1166-1170.
58. Seliger SL, Longstreth WT Jr (2008) Lessons about brain vascular disease from another pulsating organ, the kidney. Stroke 39, 5-6.